What we tested, and what actually worked

Every valuation measure we could test, inside every kind of business, over 213282 PIT company-quarters 2006-2026, delisted included. A measure only counts when the cheapest fifth of companies beat the dearest by a margin that held in every period we tested and that survives resampling. Most do not. The failures are listed below the successes, deliberately: a list of only the winners would tell you nothing about how hard they were to find.

Study AV-01 · generated 2026-09-20 · benchmark: S&P 500 total return over the same window · 206 combinations tested, 2 beat the index, 48 were real but still lost to it.

What actually beat the market

The hardest bar, and the only one that would justify buying something: the cheap group had to beat the S&P 500, not merely fall less than the expensive group.

Business typeMeasure HorizonCheapest fifth Gap to dearestSample Evidence
Pipeline / MLP Operating cash flow yield 36m +4.1 pts +25.4 pts 793 robust
Pipeline / MLP Operating cash flow yield 24m +1.4 pts +18.3 pts 920 robust

Real, but not a reason to buy: "lost less"

These 48 findings passed every statistical test — the gap between cheap and expensive is real and held across periods. But both groups lost to the index; the cheap ones simply lost less. Among small and unprofitable companies that is what "value" mostly means, and it is not a case for owning them. We list them because the gap is genuine and because leaving them out would make the section above look easier to find than it was.

Business typeMeasure HorizonCheapest fifth Dearest fifthBeat the index Sample
Pre-profit medical devices Earnings yield (EBIT / EV) 36m -34.2 pts -113.8 pts 31% 1,181
Pre-profit medical devices Earnings yield (EBIT / EV) 24m -18.5 pts -82.1 pts 37% 1,386
Pre-profit medical devices Operating cash flow yield 24m -40.9 pts -95.4 pts 28% 2,559
Pre-profit medical devices Operating cash flow yield 36m -71.1 pts -123.3 pts 20% 2,081
Pre-profit medical devices Operating cash flow yield 12m -18.6 pts -61.6 pts 37% 3,064
Clinical-stage biotech Earnings yield (EBIT / EV) 36m -76.4 pts -118.4 pts 23% 1,736
Pre-profit medical devices Earnings yield (EBIT / EV) 12m -8.8 pts -50.5 pts 39% 1,576
Clinical-stage biotech Earnings yield (EBIT / EV) 24m -44.2 pts -78.0 pts 28% 2,183
Pre-profit / cash-burning company Earnings yield (EBIT / EV) 36m -23.2 pts -53.4 pts 36% 14,707
Pre-profit medical devices EV / Sales 24m -54.1 pts -24.4 pts 25% 1,232
Profitable medical devices EV / Sales 36m -49.4 pts -22.5 pts 24% 979
Pre-profit / cash-burning company Earnings yield (EBIT / EV) 24m -14.3 pts -38.1 pts 39% 16,353
Clinical-stage biotech Earnings yield (EBIT / EV) 12m -22.4 pts -43.8 pts 32% 2,665
Regulated utility Operating cash flow yield 36m -13.1 pts -34.5 pts 36% 2,832
Profitable medical devices Operating cash flow yield 36m -16.7 pts -36.3 pts 41% 2,138
Clinical-stage biotech Operating cash flow yield 24m -57.1 pts -76.3 pts 25% 10,145
Clinical-stage biotech Operating cash flow yield 36m -91.2 pts -109.3 pts 18% 8,079
Insurance underwriter Operating cash flow yield 24m -0.7 pts -18.4 pts 49% 3,206
Pre-profit / cash-burning company Earnings yield (EBIT / EV) 12m -6.0 pts -23.2 pts 44% 18,227
Insurance underwriter Operating cash flow yield 36m -4.5 pts -21.6 pts 48% 2,811
Clinical-stage biotech Operating cash flow yield 12m -27.6 pts -43.9 pts 31% 12,399
Regulated utility Operating cash flow yield 24m -5.7 pts -21.8 pts 42% 3,159
Profitable medical devices Earnings yield (EBIT / EV) 36m -13.9 pts -29.4 pts 40% 1,097
Profitable medical devices Earnings yield (EBIT / EV) 24m -5.6 pts -20.3 pts 46% 1,267
Pre-profit / cash-burning company Operating cash flow yield 12m -14.1 pts -28.4 pts 37% 21,978
Regulated utility Earnings yield (EBIT / EV) 36m -12.2 pts -26.3 pts 34% 2,806
Pre-profit / cash-burning company Operating cash flow yield 24m -30.5 pts -43.8 pts 31% 18,667
Insurance underwriter Operating cash flow yield 12m -1.3 pts -13.1 pts 49% 3,626
Regulated utility Earnings yield (EBIT / EV) 24m -4.6 pts -16.3 pts 42% 3,113
Pipeline / MLP EV / EBIT 36m -5.0 pts -16.4 pts 46% 700
Profitable medical devices Operating cash flow yield 24m -10.6 pts -21.1 pts 42% 2,436
Profitable medical devices Earnings yield (EBIT / EV) 12m -2.4 pts -11.3 pts 47% 1,460
Regulated utility Operating cash flow yield 12m -2.2 pts -10.6 pts 45% 3,500
Cyclical semiconductor / hardware EV / Sales 24m -6.6 pts +1.5 pts 44% 1,748
Stable cash-generating business Earnings yield (EBIT / EV) 24m -14.1 pts -20.9 pts 40% 30,925
Pipeline / MLP Price / Earnings 12m -10.6 pts -3.8 pts 31% 503
Stable cash-generating business Earnings yield (EBIT / EV) 36m -23.4 pts -29.8 pts 37% 26,930
Commodity producer Price / Book 12m -18.7 pts -24.1 pts 37% 6,884
Pre-profit medical devices Price / Earnings 12m -12.0 pts -6.6 pts 39% 487
Commodity producer Price / Book 24m -40.8 pts -46.0 pts 33% 6,066
Bank Operating cash flow yield 12m -0.8 pts -5.5 pts 49% 11,762
Stable cash-generating business EV / Sales 36m -24.2 pts -19.7 pts 38% 23,386
Stable cash-generating business Price / Book 12m -10.4 pts -6.0 pts 39% 47,468
Stable cash-generating business Earnings yield (EBIT / EV) 12m -5.7 pts -9.6 pts 44% 35,237
Insurance underwriter Price / Earnings 12m -1.2 pts -4.8 pts 49% 2,674
Commodity producer Price / Book 36m -58.4 pts -61.8 pts 28% 5,305
Stable cash-generating business Price / Earnings 24m -12.7 pts -16.1 pts 40% 30,538
Bank Price / Book 12m -0.8 pts -2.4 pts 49% 11,296

What did not work at all

These were tested on exactly the same data and are shown so you can see the denominator. A measure fails either because it worked in one period and reversed in another, or because the result cannot be separated from chance.

Business typeMeasure HorizonGap SampleWhy it failed
Bank EV / EBIT 12m +1.4 pts 2,477 Cannot be told apart from chance.
Bank EV / EBIT 24m +5.5 pts 2,092 Cannot be told apart from chance.
Bank EV / EBIT 36m +8.1 pts 1,711 Cannot be told apart from chance.
Bank EV / Sales 12m +1.5 pts 1,371 Cannot be told apart from chance.
Bank EV / Sales 24m +1.3 pts 1,161 Cannot be told apart from chance.
Bank EV / Sales 36m +6.2 pts 971 Cannot be told apart from chance.
Bank Operating cash flow yield 24m +3.8 pts 10,207 Worked in one period and reversed in another — not usable.
Bank Operating cash flow yield 36m +6.5 pts 8,788 Worked in one period and reversed in another — not usable.
Bank Earnings yield (EBIT / EV) 12m +0.1 pts 2,645 Cannot be told apart from chance.
Bank Earnings yield (EBIT / EV) 24m +4.3 pts 2,185 Cannot be told apart from chance.
Bank Earnings yield (EBIT / EV) 36m +7.3 pts 1,773 Cannot be told apart from chance.
Bank Price / Book 24m +4.8 pts 10,016 Worked in one period and reversed in another — not usable.
Bank Price / Book 36m +7.0 pts 8,872 Worked in one period and reversed in another — not usable.
Bank Price / Earnings 12m +4.2 pts 2,983 Cannot be told apart from chance.
Bank Price / Earnings 24m +5.6 pts 2,590 Cannot be told apart from chance.
Bank Price / Earnings 36m +10.2 pts 2,237 Cannot be told apart from chance.
Clinical-stage biotech EV / Sales 12m -5.1 pts 1,668 Cannot be told apart from chance.
Clinical-stage biotech EV / Sales 24m +0.3 pts 1,372 Cannot be told apart from chance.
Clinical-stage biotech EV / Sales 36m -16.7 pts 1,101 Cannot be told apart from chance.
Clinical-stage biotech Price / Book 12m -7.9 pts 8,761 Cannot be told apart from chance.
Clinical-stage biotech Price / Book 24m -2.5 pts 7,154 Cannot be told apart from chance.
Clinical-stage biotech Price / Book 36m -6.7 pts 5,799 Cannot be told apart from chance.
Commodity producer EV / EBIT 12m -3.6 pts 3,352 Cannot be told apart from chance.
Commodity producer EV / EBIT 24m +4.0 pts 2,921 Cannot be told apart from chance.
Commodity producer EV / EBIT 36m -4.0 pts 2,510 Cannot be told apart from chance.
Commodity producer EV / Sales 12m +4.1 pts 4,224 Cannot be told apart from chance.
Commodity producer EV / Sales 24m +8.3 pts 3,689 Cannot be told apart from chance.
Commodity producer EV / Sales 36m +16.3 pts 3,177 Cannot be told apart from chance.
Commodity producer Operating cash flow yield 12m +8.5 pts 7,048 Worked in one period and reversed in another — not usable.
Commodity producer Operating cash flow yield 24m +8.7 pts 6,135 Worked in one period and reversed in another — not usable.
Commodity producer Operating cash flow yield 36m +6.2 pts 5,312 Worked in one period and reversed in another — not usable.
Commodity producer Earnings yield (EBIT / EV) 12m +11.8 pts 5,413 Cannot be told apart from chance.
Commodity producer Earnings yield (EBIT / EV) 24m +22.0 pts 4,711 Cannot be told apart from chance.
Commodity producer Earnings yield (EBIT / EV) 36m +21.0 pts 4,043 Cannot be told apart from chance.
Commodity producer Price / Earnings 12m -3.6 pts 3,057 Cannot be told apart from chance.
Commodity producer Price / Earnings 24m -6.4 pts 2,688 Cannot be told apart from chance.
Commodity producer Price / Earnings 36m -8.8 pts 2,285 Cannot be told apart from chance.
Cyclical semiconductor / hardware EV / EBIT 12m -2.6 pts 1,782 Cannot be told apart from chance.
Cyclical semiconductor / hardware EV / EBIT 24m -3.1 pts 1,586 Cannot be told apart from chance.
Cyclical semiconductor / hardware EV / EBIT 36m -5.5 pts 1,391 Worked in one period and reversed in another — not usable.
Cyclical semiconductor / hardware EV / Sales 12m -3.9 pts 1,991 Worked in one period and reversed in another — not usable.
Cyclical semiconductor / hardware EV / Sales 36m -0.4 pts 1,519 Cannot be told apart from chance.
Cyclical semiconductor / hardware Operating cash flow yield 12m -1.1 pts 3,996 Cannot be told apart from chance.
Cyclical semiconductor / hardware Operating cash flow yield 24m +3.1 pts 3,512 Cannot be told apart from chance.
Cyclical semiconductor / hardware Operating cash flow yield 36m +11.3 pts 3,076 Cannot be told apart from chance.
Cyclical semiconductor / hardware Earnings yield (EBIT / EV) 12m -0.8 pts 2,251 Cannot be told apart from chance.
Cyclical semiconductor / hardware Earnings yield (EBIT / EV) 24m +4.6 pts 1,983 Cannot be told apart from chance.
Cyclical semiconductor / hardware Earnings yield (EBIT / EV) 36m +5.3 pts 1,728 Cannot be told apart from chance.
Cyclical semiconductor / hardware Price / Book 12m -0.1 pts 3,305 Cannot be told apart from chance.
Cyclical semiconductor / hardware Price / Book 24m -1.8 pts 2,910 Cannot be told apart from chance.
Cyclical semiconductor / hardware Price / Book 36m +2.1 pts 2,561 Cannot be told apart from chance.
Cyclical semiconductor / hardware Price / Earnings 12m -1.4 pts 2,565 Cannot be told apart from chance.
Cyclical semiconductor / hardware Price / Earnings 24m -0.1 pts 2,301 Cannot be told apart from chance.
Cyclical semiconductor / hardware Price / Earnings 36m -2.2 pts 2,061 Cannot be told apart from chance.
Insurance underwriter EV / EBIT 12m -0.7 pts 852 Cannot be told apart from chance.
Insurance underwriter EV / EBIT 24m +0.1 pts 711 Cannot be told apart from chance.
Insurance underwriter EV / EBIT 36m -10.7 pts 592 Cannot be told apart from chance.
Insurance underwriter EV / Sales 12m -4.0 pts 1,453 Cannot be told apart from chance.
Insurance underwriter EV / Sales 24m +11.6 pts 1,252 Worked in one period and reversed in another — not usable.
Insurance underwriter EV / Sales 36m +22.0 pts 1,083 Worked in one period and reversed in another — not usable.
Insurance underwriter Earnings yield (EBIT / EV) 12m +2.7 pts 1,091 Cannot be told apart from chance.
Insurance underwriter Earnings yield (EBIT / EV) 24m +0.6 pts 910 Cannot be told apart from chance.
Insurance underwriter Earnings yield (EBIT / EV) 36m -9.3 pts 766 Worked in one period and reversed in another — not usable.
Insurance underwriter Price / Book 12m -4.3 pts 3,534 Cannot be told apart from chance.
Insurance underwriter Price / Book 24m -3.9 pts 3,175 Cannot be told apart from chance.
Insurance underwriter Price / Book 36m -9.0 pts 2,846 Cannot be told apart from chance.
Insurance underwriter Price / Earnings 24m +5.2 pts 2,404 Cannot be told apart from chance.
Insurance underwriter Price / Earnings 36m +2.9 pts 2,144 Cannot be told apart from chance.
Pre-profit medical devices EV / Sales 12m -15.7 pts 1,399 Cannot be told apart from chance.
Pre-profit medical devices EV / Sales 36m -36.5 pts 1,055 Worked in one period and reversed in another — not usable.
Pre-profit medical devices Price / Book 12m -0.8 pts 3,269 Cannot be told apart from chance.
Pre-profit medical devices Price / Book 24m +0.1 pts 2,841 Cannot be told apart from chance.
Pre-profit medical devices Price / Book 36m -5.2 pts 2,433 Cannot be told apart from chance.
Pre-profit medical devices Price / Earnings 24m +8.7 pts 446 Cannot be told apart from chance.
Pre-profit medical devices Price / Earnings 36m +16.5 pts 401 Cannot be told apart from chance.
Profitable medical devices EV / EBIT 12m +0.8 pts 1,152 Cannot be told apart from chance.
Profitable medical devices EV / EBIT 24m +8.1 pts 1,005 Worked in one period and reversed in another — not usable.
Profitable medical devices EV / EBIT 36m +5.8 pts 865 Worked in one period and reversed in another — not usable.
Profitable medical devices EV / Sales 12m -5.9 pts 1,305 Cannot be told apart from chance.
Profitable medical devices EV / Sales 24m -9.9 pts 1,135 Cannot be told apart from chance.
Profitable medical devices Operating cash flow yield 12m +2.2 pts 2,767 Cannot be told apart from chance.
Profitable medical devices Price / Book 12m -5.6 pts 2,240 Cannot be told apart from chance.
Profitable medical devices Price / Book 24m -9.9 pts 1,990 Worked in one period and reversed in another — not usable.
Profitable medical devices Price / Book 36m -9.1 pts 1,765 Cannot be told apart from chance.
Profitable medical devices Price / Earnings 12m -3.0 pts 1,806 Cannot be told apart from chance.
Profitable medical devices Price / Earnings 24m +1.9 pts 1,611 Cannot be told apart from chance.
Profitable medical devices Price / Earnings 36m +12.9 pts 1,418 Cannot be told apart from chance.
Pipeline / MLP EV / EBIT 12m +5.8 pts 901 Cannot be told apart from chance.
Pipeline / MLP EV / EBIT 24m +5.1 pts 795 Worked in one period and reversed in another — not usable.
Pipeline / MLP EV / Sales 12m -3.5 pts 654 Cannot be told apart from chance.
Pipeline / MLP EV / Sales 24m -5.1 pts 570 Cannot be told apart from chance.
Pipeline / MLP EV / Sales 36m +0.9 pts 484 Cannot be told apart from chance.
Pipeline / MLP Operating cash flow yield 12m +6.7 pts 1,052 Worked in one period and reversed in another — not usable.
Pipeline / MLP Earnings yield (EBIT / EV) 12m +0.7 pts 1,079 Cannot be told apart from chance.
Pipeline / MLP Earnings yield (EBIT / EV) 24m +8.8 pts 954 Cannot be told apart from chance.
Pipeline / MLP Earnings yield (EBIT / EV) 36m +17.1 pts 844 Cannot be told apart from chance.
Pipeline / MLP Price / Book 12m -4.1 pts 898 Cannot be told apart from chance.
Pipeline / MLP Price / Book 24m +3.0 pts 802 Cannot be told apart from chance.
Pipeline / MLP Price / Book 36m +23.1 pts 700 Worked in one period and reversed in another — not usable.
Pipeline / MLP Price / Earnings 24m -6.5 pts 441 Worked in one period and reversed in another — not usable.
Pre-profit / cash-burning company EV / EBIT 12m +1.0 pts 11,178 Cannot be told apart from chance.
Pre-profit / cash-burning company EV / EBIT 24m +1.3 pts 10,341 Cannot be told apart from chance.
Pre-profit / cash-burning company EV / EBIT 36m +1.1 pts 9,526 Cannot be told apart from chance.
Pre-profit / cash-burning company EV / Sales 12m -2.7 pts 14,930 Cannot be told apart from chance.
Pre-profit / cash-burning company EV / Sales 24m -2.2 pts 13,328 Cannot be told apart from chance.
Pre-profit / cash-burning company EV / Sales 36m 0.0 pts 11,935 Cannot be told apart from chance.
Pre-profit / cash-burning company Operating cash flow yield 36m +9.8 pts 15,879 Cannot be told apart from chance.
Pre-profit / cash-burning company Price / Book 12m -2.3 pts 29,650 Cannot be told apart from chance.
Pre-profit / cash-burning company Price / Book 24m -1.4 pts 26,544 Cannot be told apart from chance.
Pre-profit / cash-burning company Price / Book 36m -3.5 pts 23,811 Cannot be told apart from chance.
Pre-profit / cash-burning company Price / Earnings 12m +1.0 pts 12,200 Cannot be told apart from chance.
Pre-profit / cash-burning company Price / Earnings 24m +1.8 pts 11,331 Cannot be told apart from chance.
Pre-profit / cash-burning company Price / Earnings 36m +1.8 pts 10,455 Cannot be told apart from chance.
Equity REIT EV / EBIT 12m -3.2 pts 1,273 Cannot be told apart from chance.
Equity REIT EV / EBIT 24m -1.2 pts 1,133 Cannot be told apart from chance.
Equity REIT EV / EBIT 36m -3.2 pts 996 Cannot be told apart from chance.
Equity REIT EV / Sales 12m -5.4 pts 1,637 Cannot be told apart from chance.
Equity REIT EV / Sales 24m -12.4 pts 1,442 Cannot be told apart from chance.
Equity REIT EV / Sales 36m -18.6 pts 1,268 Cannot be told apart from chance.
Equity REIT Operating cash flow yield 12m +1.3 pts 7,412 Cannot be told apart from chance.
Equity REIT Operating cash flow yield 24m -0.5 pts 6,586 Cannot be told apart from chance.
Equity REIT Operating cash flow yield 36m -0.5 pts 5,802 Worked in one period and reversed in another — not usable.
Equity REIT Earnings yield (EBIT / EV) 12m +1.4 pts 1,519 Cannot be told apart from chance.
Equity REIT Earnings yield (EBIT / EV) 24m +10.9 pts 1,337 Cannot be told apart from chance.
Equity REIT Earnings yield (EBIT / EV) 36m +8.0 pts 1,177 Cannot be told apart from chance.
Equity REIT Price / Book 12m -2.5 pts 7,669 Cannot be told apart from chance.
Equity REIT Price / Book 24m -2.7 pts 6,890 Worked in one period and reversed in another — not usable.
Equity REIT Price / Book 36m -7.9 pts 6,157 Worked in one period and reversed in another — not usable.
Equity REIT Price / Earnings 12m +2.3 pts 4,100 Cannot be told apart from chance.
Equity REIT Price / Earnings 24m +3.5 pts 3,680 Cannot be told apart from chance.
Equity REIT Price / Earnings 36m +6.4 pts 3,258 Worked in one period and reversed in another — not usable.
Stable cash-generating business EV / EBIT 12m -0.2 pts 28,285 Cannot be told apart from chance.
Stable cash-generating business EV / EBIT 24m -2.4 pts 24,911 Cannot be told apart from chance.
Stable cash-generating business EV / EBIT 36m -3.9 pts 21,768 Cannot be told apart from chance.
Stable cash-generating business EV / Sales 12m -1.8 pts 30,597 Cannot be told apart from chance.
Stable cash-generating business EV / Sales 24m -1.9 pts 26,870 Cannot be told apart from chance.
Stable cash-generating business Operating cash flow yield 12m +0.4 pts 56,126 Cannot be told apart from chance.
Stable cash-generating business Operating cash flow yield 24m +1.8 pts 49,199 Cannot be told apart from chance.
Stable cash-generating business Operating cash flow yield 36m +2.6 pts 42,740 Cannot be told apart from chance.
Stable cash-generating business Price / Book 24m -4.8 pts 42,071 Cannot be told apart from chance.
Stable cash-generating business Price / Book 36m -7.1 pts 37,116 Cannot be told apart from chance.
Stable cash-generating business Price / Earnings 12m +1.9 pts 34,546 Cannot be told apart from chance.
Stable cash-generating business Price / Earnings 36m +3.8 pts 26,790 Cannot be told apart from chance.
Regulated utility EV / EBIT 12m +2.2 pts 2,834 Cannot be told apart from chance.
Regulated utility EV / EBIT 24m +4.9 pts 2,584 Cannot be told apart from chance.
Regulated utility EV / EBIT 36m +2.0 pts 2,328 Cannot be told apart from chance.
Regulated utility EV / Sales 12m +0.1 pts 2,262 Cannot be told apart from chance.
Regulated utility EV / Sales 24m -3.3 pts 2,062 Worked in one period and reversed in another — not usable.
Regulated utility EV / Sales 36m -11.5 pts 1,857 Cannot be told apart from chance.
Regulated utility Earnings yield (EBIT / EV) 12m +3.2 pts 3,420 Worked in one period and reversed in another — not usable.
Regulated utility Price / Book 12m +0.8 pts 3,551 Cannot be told apart from chance.
Regulated utility Price / Book 24m +1.9 pts 3,211 Cannot be told apart from chance.
Regulated utility Price / Book 36m +2.7 pts 2,895 Cannot be told apart from chance.
Regulated utility Price / Earnings 12m +3.4 pts 1,867 Cannot be told apart from chance.
Regulated utility Price / Earnings 24m +3.7 pts 1,690 Cannot be told apart from chance.
Regulated utility Price / Earnings 36m +10.5 pts 1,515 Cannot be told apart from chance.
This page is half the story. It covers measures tested for this study. Separately we keep a register of everything we stopped showing — measures that were on the site, sometimes for years, until they were tested and failed. It includes our own composite risk score, Shiller CAPE as a risk read, the price-trend chip, and one case where the signal turned out to be a bug in our own code.

How this was measured

  • Every figure is taken as it stood on the day the filing reached the SEC — never a restated number, and never one published after the date it is used on.
  • The price history includes companies that were later delisted, carrying whatever actually happened to them. A study run only on today's survivors would flatter every result on this page.
  • Companies are ranked against others of the same business type in the same quarter, so a cheap market cannot be mistaken for a cheap company.
  • The periods are tested separately. A measure that works in one and reverses in another is marked as such, not averaged into looking useful.
  • Confidence comes from resampling whole quarters, which keeps months that moved together from counting as independent evidence.

Testing many combinations at once means a few will look good by luck. That is why agreement across periods is required as well as statistical significance, and why the count of everything tested is printed above rather than only the winners.